Strategies to overcome drug resistance using SHP2 inhibitors

Encoded by PTPN11, the SHP2 (Src homology-2 domain-containing protein tyrosine phosphatase-2) is widely recognized as a carcinogenic phosphatase. As a promising anti-cancer drug target, SHP2 regulates many signaling pathways such as RAS-RAF-ERK, PI3K-AKT and JAK-STAT. Meanwhile, SHP2 plays a signifi...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Meng, Gao, Shan, Elhassan, Reham M., Hou, Xuben, Fang, Hao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8727779/
https://www.ncbi.nlm.nih.gov/pubmed/35024315
http://dx.doi.org/10.1016/j.apsb.2021.03.037

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8727779/
https://www.ncbi.nlm.nih.gov/pubmed/35024315
http://dx.doi.org/10.1016/j.apsb.2021.03.037

Ejemplares similares